|
|
|
|
LEADER |
01627nam a2200229 u 4500 |
001 |
EB002001425 |
003 |
EBX01000000000000001164326 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
245 |
0 |
0 |
|a Direct lateral interbody fusion in patients requiring surgery for spinal instability
|h Elektronische Ressource
|b a review of the comparative clinical and cost-effectiveness, and guidelines
|
260 |
|
|
|a [Ottawa]
|b Canadian Agency for Drugs and Technologies in Health
|c 25 June 2015, 2015
|
300 |
|
|
|a 1 PDF file (58 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a Rapid response report: summary with critical appraisal
|
500 |
|
|
|a Title from PDF caption title
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK304466
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The purpose of this report is to retrieve and review the existing evidence of clinical effectiveness, and safety of direct lateral interbody fusion (DLIF) in patients requiring surgery for spinal instability. In addition this report aims to examine the available evidence for comparative clinical effectiveness, and cost-effectiveness of DLIF as compared to other surgical lumbar fusion techniques in single and multiple transpsoas fusions for the treatment of spinal instability. Finally this report aims to retrieve and review available guidelines on performing DLIF in patients requiring surgery for spinal instability
|